Wes Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WES PHARMA INC
WES PHARMA INC has five approved drugs.
Summary for Wes Pharma Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Wes Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wes Pharma Inc | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 209069-001 | Jul 17, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wes Pharma Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 207510-002 | Mar 21, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wes Pharma Inc | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 213062-001 | Jun 6, 2022 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
